{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:57:45Z","timestamp":1769083065752,"version":"3.49.0"},"reference-count":148,"publisher":"American Veterinary Medical Association (AVMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>To compare concentrations of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in aqueous humor from ophthalmologically normal dogs and dogs with naturally occurring primary angle-closure glaucoma (cPACG).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>SAMPLE<\/jats:title>\n<jats:p>Aqueous humor samples from 12 eyes with cPACG and 18 ophthalmologically normal eyes of dogs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>PROCEDURES<\/jats:title>\n<jats:p>A multiplex fluorescence-based ELISA was used to measure concentrations of MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, MMP-13, TIMP-1, TIMP-2, and TIMP-4. Results for eyes with versus without cPACG were compared.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Significantly higher mean concentrations of MMP-1 (45% higher), MMP-2 (55% higher), MMP-3 (39% higher), MMP-8 (79% higher), MMP-9 (29% higher), MMP-10 (60% higher), TIMP-1 (63% higher), and TIMP-2 (136% higher) were detected in aqueous humor from eyes with cPACG, compared with ophthalmologically normal eyes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CLINICAL RELEVANCE<\/jats:title>\n<jats:p>MMPs and TIMPs have pivotal roles in extracellular matrix turnover and homeostasis in the outflow pathways of the eye. Results of the present study documented higher concentrations of MMPs and TIMPs in aqueous humor samples from dog eyes with late-stage cPACG. Although, to our knowledge, TIMPs have not previously been evaluated in the context of cPACG, the markedly higher concentration of TIMPs in eyes with cPACG suggested that inhibition of proteolysis and extracellular matrix turnover might be a factor in the development of glaucoma in susceptible individuals. However, because the present study used samples from dogs with late-stage cPACG, further work is required to characterize the temporal relationship between MMP and TIMP concentration changes and onset or progression of disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2460\/ajvr.21.04.0062","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T16:28:21Z","timestamp":1640104101000},"page":"245-255","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of matrix metalloproteinases and tissue inhibitors of metalloproteinases in aqueous humor of dogs with versus without naturally occurring primary angle-closure glaucoma"],"prefix":"10.2460","volume":"83","author":[{"given":"Stephanie A.","family":"Pumphrey","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Zitek-Morrison","sequence":"additional","affiliation":[{"name":"Department of Population and Quantitative Health Sciences, UMass Chan Medical School, University of Massachusetts, Worcester, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Pizzirani","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn M.","family":"Meola","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"issue":"2","key":"ref1","series-title":"Vet Ophthalmol.","first-page":"97","article-title":"Prevalence of the breed-related glaucomas in pure-bred dogs in North America","volume":"7","author":"Gelatt KN","year":"2004","unstructured":"Gelatt KN, MacKay EO. Prevalence of the breed-related glaucomas in pure-bred dogs in North America. Vet Ophthalmol. 2004;7(2):97\u2013111. doi: 10.1111\/j.1463-5224.2004.04006.x"},{"key":"ref2","series-title":"Veterinary Ophthalmology","first-page":"1050","article-title":"The canine glaucomas","author":"Plummer CE","year":"2013","unstructured":"Plummer CE, Regnier A, Gelatt KN. The canine glaucomas. In: Gelatt KN, Gilger BC, Kern TJ, eds. Veterinary Ophthalmology. 5th ed. John Wiley & Sons Inc; 2013:1050\u20131145."},{"issue":"5","key":"ref3","series-title":"Vet Ophthalmol.","first-page":"726","article-title":"The future of canine glaucoma therapy","volume":"22","author":"Kom\u00e1romy AM","year":"2019","unstructured":"Kom\u00e1romy AM, Bras D, Esson DW,  The future of canine glaucoma therapy. Vet Ophthalmol. 2019;22(5):726\u2013740. doi: 10.1111\/vop.12678"},{"issue":"2","key":"ref4","series-title":"Vet Pathol.","first-page":"194","article-title":"Genetic and biochemical biomarkers in canine glaucoma","volume":"54","author":"Graham KL","year":"2017","unstructured":"Graham KL, McCowan C, White A. Genetic and biochemical biomarkers in canine glaucoma. Vet Pathol. 2017;54(2):194\u2013203. doi: 10.1177\/0300985816666611"},{"issue":"suppl 1","key":"ref5","series-title":"Vet Ophthalmol.","first-page":"108","article-title":"Identification of ocular matrix metalloproteinases present within the aqueous humor and iridocorneal drainage angle tissue of normal and glaucomatous canine eyes","volume":"10","author":"Weinstein WL","year":"2007","unstructured":"Weinstein WL, Dietrich UM, Sapienza JS, Carmichael KP, Moore PA, Krunkosky TM. Identification of ocular matrix metalloproteinases present within the aqueous humor and iridocorneal drainage angle tissue of normal and glaucomatous canine eyes. Vet Ophthalmol. 2007;10(suppl 1):108\u2013116. doi: 10.1111\/j.1463-5224.2007.00586.x"},{"issue":"1","key":"ref6","series-title":"Vet Ophthalmol.","first-page":"25","article-title":"A variant in OLFML3 is associated with pectinate ligament abnormality and primary closed-angle glaucoma in Border Collies from the United Kingdom","volume":"23","author":"Oliver JAC","year":"2020","unstructured":"Oliver JAC, Wright H, Massidda PA, Burmeister LM, Mellersh CS. A variant in OLFML3 is associated with pectinate ligament abnormality and primary closed-angle glaucoma in Border Collies from the United Kingdom. Vet Ophthalmol. 2020;23(1):25\u201336. doi: 10.1111\/vop.12680"},{"key":"ref7","series-title":"Mol Vis.","first-page":"93","article-title":"Primary closed angle in the Basset Hound: genetic investigations using genome-wide association and RNA sequencing strategies","volume":"25","author":"Oliver JAC","year":"2019","unstructured":"Oliver JAC, Ricketts SL, Kuehn MH, Mellersh CS. Primary closed angle in the Basset Hound: genetic investigations using genome-wide association and RNA sequencing strategies. Mol Vis. 2019;25:93\u2013105."},{"issue":"9","key":"ref8","series-title":"PLoS One.","first-page":"e74372","article-title":"Dogs and humans share a common susceptibility gene SRBD1 for glaucoma risk","volume":"8","author":"Kanemaki N","year":"2013","unstructured":"Kanemaki N, Tchedre KT, Imayasu M,  Dogs and humans share a common susceptibility gene SRBD1 for glaucoma risk. PLoS One. 2013;8(9):e74372. doi: 10.1371\/journal.pone.0074372"},{"issue":"7","key":"ref9","series-title":"Clin Anat.","first-page":"1031","article-title":"Histological investigation of human glaucomatous eyes: extracellular fibrotic changes and galectin 3 expression in the trabecular meshwork and optic nerve head","volume":"31","author":"Belmares R","year":"2018","unstructured":"Belmares R, Raychaudhuri U, Maanssoon S, Clark AF. Histological investigation of human glaucomatous eyes: extracellular fibrotic changes and galectin 3 expression in the trabecular meshwork and optic nerve head. Clin Anat. 2018;31(7):1031\u20131049. doi: 10.1002\/ca.23263"},{"issue":"7","key":"ref10","series-title":"Expert Opin Ther Targets.","first-page":"629","article-title":"Trabecular meshwork ECM remodeling in glaucoma: could RAS be a target?","volume":"22","author":"Agarwal P","year":"2018","unstructured":"Agarwal P, Agarwal R. Trabecular meshwork ECM remodeling in glaucoma: could RAS be a target? Expert Opin Ther Targets. 2018;22(7):629\u2013638. doi: 10.1080\/14728222.2018.1486822"},{"issue":"1","key":"ref11","series-title":"Sci Rep.","first-page":"14951","article-title":"Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork","volume":"7","author":"Kasetti RB","year":"2017","unstructured":"Kasetti RB, Maddineni P, Millar JC, Clark AF, Zode GS. Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork. Sci Rep. 2017;7(1):14951. doi: 10.1038\/s41598-017-14938-0"},{"issue":"2","key":"ref12","series-title":"Curr Opin Ophthalmol.","first-page":"135","article-title":"Current understanding of conventional outflow dysfunction in glaucoma","volume":"23","author":"Stamer WD","year":"2012","unstructured":"Stamer WD, Acott TS. Current understanding of conventional outflow dysfunction in glaucoma. Curr Opin Ophthalmol. 2012;23(2):135\u2013143. doi: 10.1097\/ICU.0b013e32834ff23e"},{"key":"ref13","series-title":"Exp Eye Res.","first-page":"112","article-title":"Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma","volume":"133","author":"Vranka JA","year":"2015","unstructured":"Vranka JA, Kelley MJ, Acott TS, Keller KE. Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma. Exp Eye Res. 2015;133:112\u2013125. doi: 10.1016\/j.exer.2014.07.014"},{"issue":"3","key":"ref14","series-title":"Cells.","first-page":"687","article-title":"Cell-matrix interactions in the eye: from cornea to choroid","volume":"10","author":"Pouw AE","year":"2021","unstructured":"Pouw AE, Greiner MA, Coussa RG,  Cell-matrix interactions in the eye: from cornea to choroid. Cells. 2021;10(3):687. doi: 10.3390\/cells10030687"},{"issue":"3","key":"ref15","series-title":"Curr Eye Res.","first-page":"276","article-title":"Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression","volume":"17","author":"Alexander JP","year":"1998","unstructured":"Alexander JP, Samples JR, Acott TS. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr Eye Res. 1998;17(3):276\u2013285. doi: 10.1076\/ceyr.17.3.276.5219"},{"issue":"1","key":"ref16","series-title":"Invest Ophthalmol Vis Sci.","first-page":"172","article-title":"Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork","volume":"32","author":"Alexander JP","year":"1991","unstructured":"Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32(1):172\u2013180."},{"issue":"5","key":"ref17","series-title":"Exp Eye Res.","first-page":"481","article-title":"Matrix metalloproteinases and their inhibitors in aqueous humor","volume":"62","author":"Huang SH","year":"1996","unstructured":"Huang SH, Adamis AP, Wiederschain DG, Shima DT, Shing Y, Moses MA. Matrix metalloproteinases and their inhibitors in aqueous humor. Exp Eye Res. 1996;62(5):481\u2013490. doi: 10.1006\/exer.1996.0058"},{"issue":"12","key":"ref18","series-title":"Invest Ophthalmol Vis Sci.","first-page":"7756","article-title":"MMPs in the trabecular meshwork: promising targets for future glaucoma therapies?","volume":"54","author":"De Groef L","year":"2013","unstructured":"De Groef L, Van Hove I, Dekeyster E, Stalmans I, Moons L. MMPs in the trabecular meshwork: promising targets for future glaucoma therapies? Invest Ophthalmol Vis Sci. 2013;54(12):7756\u20137763. doi: 10.1167\/iovs.13-13088"},{"issue":"3","key":"ref19","series-title":"Invest Ophthalmol Vis Sci.","first-page":"401","article-title":"Tissue plasminogen activator in cultured human trabecular meshwork cells. Predominance of enzyme over plasminogen activator inhibitor","volume":"29","author":"Shuman MA","year":"1988","unstructured":"Shuman MA, Polansky JR, Merkel C, Alvarado JA. Tissue plasminogen activator in cultured human trabecular meshwork cells. Predominance of enzyme over plasminogen activator inhibitor. Invest Ophthalmol Vis Sci. 1988;29(3):401\u2013405."},{"issue":"1","key":"ref20","series-title":"Ophthalmologe.","first-page":"73","article-title":"Plasminogen activator and PAI. Detection in aqueous humor of the human eye. Article in German","volume":"90","author":"Steinkamp GW","year":"1993","unstructured":"Steinkamp GW, Hattenbach LO, Heider HW, Scharrer I. Plasminogen activator and PAI. Detection in aqueous humor of the human eye. Article in German. Ophthalmologe. 1993;90(1):73\u201375."},{"issue":"5","key":"ref21","series-title":"Exp Eye Res.","first-page":"545","article-title":"Localization of urokinase-type plasminogen activator in human eyes: an immunocytochemical study","volume":"51","author":"Tripathi RC","year":"1990","unstructured":"Tripathi RC, Tripathi BJ, Park JK. Localization of urokinase-type plasminogen activator in human eyes: an immunocytochemical study. Exp Eye Res. 1990;51(5):545\u2013552. doi: 10.1016\/0014-4835(90)90085-9"},{"key":"ref22","series-title":"BMC Ophthalmol.","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of patients with primary angle closure glaucoma - a quantitative study","volume":"14","author":"Nga AD","year":"2014","unstructured":"Nga AD, Yap SL, Samsudin A, Abdul-Rahman PS, Hashim OH, Mimiwati Z. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of patients with primary angle closure glaucoma - a quantitative study. BMC Ophthalmol. 2014;14:33 doi: 10.1186\/1471-2415-14-33"},{"key":"ref23","series-title":"Mol Vis.","first-page":"1162","article-title":"TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients","volume":"21","author":"Ashworth Briggs EL","year":"2015","unstructured":"Ashworth Briggs EL, Toh T, Eri R, Hewitt AW, Cook AL. TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients. Mol Vis. 2015;21:1162\u20131172."},{"issue":"3","key":"ref24","series-title":"Vojnosanit Pregl.","first-page":"231","article-title":"Transforming growth factor beta1, matrix-metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation glaucoma\/syndrome","volume":"69","author":"Djordjevi\u0107-Joci\u0107 J","year":"2012","unstructured":"Djordjevi\u0107-Joci\u0107 J, Zlatanovi\u0107 G, Veselinovi\u0107 D,  Transforming growth factor beta1, matrix-metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation glaucoma\/syndrome. Vojnosanit Pregl. 2012;69(3):231\u2013236."},{"key":"ref25","series-title":"BMC Ophthalmol.","article-title":"Tissue inhibitor of metalloproteinase 4 in aqueous humor of patients with primary open angle glaucoma, pseudoexfoliation syndrome and pseudoexfoliative glaucoma and its role in proteolysis imbalance","volume":"13","author":"Fountoulakis N","year":"2013","unstructured":"Fountoulakis N, Labiris G, Aristeidou A,  Tissue inhibitor of metalloproteinase 4 in aqueous humor of patients with primary open angle glaucoma, pseudoexfoliation syndrome and pseudoexfoliative glaucoma and its role in proteolysis imbalance. BMC Ophthalmol. 2013;13:69. doi: 10.1186\/1471-2415-13-69"},{"issue":"6","key":"ref26","series-title":"Curr Eye Res.","first-page":"540","article-title":"Connective tissue growth factor and tissue inhibitor of matrix metalloproteinase-2 in patients with exfoliative glaucoma","volume":"36","author":"Ghanem AA","year":"2011","unstructured":"Ghanem AA, Arafa LF, El-Baz A. Connective tissue growth factor and tissue inhibitor of matrix metalloproteinase-2 in patients with exfoliative glaucoma. Curr Eye Res. 2011;36(6):540\u2013545. doi: 10.3109\/02713683.2011.565541"},{"issue":"2","key":"ref27","series-title":"Br J Ophthalmol.","first-page":"169","article-title":"Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome","volume":"89","author":"Ho SL","year":"2005","unstructured":"Ho SL, Dogar GF, Wang J,  Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Br J Ophthalmol. 2005;89(2):169\u2013173. doi: 10.1136\/bjo.2004.044685"},{"key":"ref28","series-title":"Biomed Res Int.","article-title":"Altered expression levels of MMP1, MMP9, MMP12, TIMP1, and IL-1\u03b2 as a risk factor for the elevated IOP and optic nerve head damage in the primary open-angle glaucoma patients","volume":"2015","author":"Markiewicz L","year":"2015","unstructured":"Markiewicz L, Pytel D, Mucha B,  Altered expression levels of MMP1, MMP9, MMP12, TIMP1, and IL-1\u03b2 as a risk factor for the elevated IOP and optic nerve head damage in the primary open-angle glaucoma patients. Biomed Res Int. 2015;2015:812503. doi: 10.1155\/2015\/812503"},{"issue":"1","key":"ref29","series-title":"J Glaucoma.","first-page":"64","article-title":"Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma","volume":"14","author":"M\u00e4\u00e4tt\u00e4 M","year":"2005","unstructured":"M\u00e4\u00e4tt\u00e4 M, Tervahartiala T, Harju M, Airaksinen J, Autio-Harmanen H, Sorsa T. Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma. J Glaucoma. 2005;14(1):64\u201369. doi: 10.1097\/01.ijg.0000145812.39224.0a"},{"issue":"5","key":"ref30","series-title":"Graefes Arch Clin Exp Ophthalmol.","first-page":"697","article-title":"Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma","volume":"245","author":"R\u00f6nkk\u00f6 S","year":"2007","unstructured":"R\u00f6nkk\u00f6 S, Rekonen P, Kaarniranta K, Puustj\u00e4rvi T, Ter\u00e4svirta M, Uusitalo H. Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol. 2007;245(5):697\u2013704. doi: 10.1007\/s00417-006-0440-1"},{"issue":"3","key":"ref31","series-title":"Invest Ophthalmol Vis Sci.","first-page":"1117","article-title":"Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome\/glaucoma and primary open-angle glaucoma","volume":"44","author":"Schl\u00f6tzer-Schrehardt U","year":"2003","unstructured":"Schl\u00f6tzer-Schrehardt U, Lommatzsch J, K\u00fcchle M, Konstas AG, Naumann GO. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome\/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2003;44(3):1117\u20131125. doi: 10.1167\/iovs.02-0365"},{"issue":"11","key":"ref32","series-title":"PLoS One.","first-page":"e111941","article-title":"A novel missense mutation in ADAMTS10 in Norwegian Elkhound primary glaucoma","volume":"9","author":"Ahonen SJ","year":"2014","unstructured":"Ahonen SJ, Kaukonen M, Nussdorfer FD, Harman CD, Kom\u00e1romy AM, Lohi H. A novel missense mutation in ADAMTS10 in Norwegian Elkhound primary glaucoma. PLoS One. 2014;9(11):e111941. doi: 10.1371\/journal.pone.0111941"},{"issue":"10","key":"ref33","series-title":"PLoS One.","first-page":"e0140436","article-title":"Two independent mutations in ADAMTS17 are associated with primary open angle glaucoma in the Basset Hound and Basset Fauve de Bretagne breeds of dog","volume":"10","author":"Oliver JA","year":"2015","unstructured":"Oliver JA, Forman OP, Pettitt L, Mellersh CS. Two independent mutations in ADAMTS17 are associated with primary open angle glaucoma in the Basset Hound and Basset Fauve de Bretagne breeds of dog. PLoS One. 2015;10(10):e0140436. doi: 10.1371\/journal.pone.0140436"},{"issue":"3","key":"ref34","series-title":"Invest Ophthalmol Vis Sci.","first-page":"1881","article-title":"Screening ADAMTS10 in dog populations supports Gly661Arg as the glaucoma-causing variant in beagles","volume":"54","author":"Kuchtey J","year":"2013","unstructured":"Kuchtey J, Kunkel J, Esson D,  Screening ADAMTS10 in dog populations supports Gly661Arg as the glaucoma-causing variant in beagles. Invest Ophthalmol Vis Sci. 2013;54(3):1881\u20131886. doi: 10.1167\/iovs.12-10796"},{"issue":"1-2","key":"ref35","series-title":"Gene.","first-page":"67","article-title":"TIMP-1 expression is increased in X-linked progressive retinal atrophy despite its exclusion as a candidate gene","volume":"225","author":"Zeiss CJ","year":"1998","unstructured":"Zeiss CJ, Acland GM, Aguirre GD, Ray K. TIMP-1 expression is increased in X-linked progressive retinal atrophy despite its exclusion as a candidate gene. Gene. 1998;225(1-2):67\u201375. doi: 10.1016\/s0378-1119(98)00521-6"},{"key":"ref36","series-title":"The Association for Research in Vision and Ophthalmology","unstructured":"Statement for the use of animals in ophthalmic and vision research. The Association for Research in Vision and Ophthalmology. Accessed July 3, 2019. https:\/\/www.arvo.org\/About\/policies\/statement-for-the-use-of-animals-in-ophthalmic-and-vision-research\/"},{"issue":"6","key":"ref37","series-title":"Vet Pathol.","first-page":"1197","article-title":"Chronic glaucoma in dogs: relationships between histologic lesions and the gonioscopic diagnosis of pectinate ligament dysplasia","volume":"53","author":"Bauer BS","year":"2016","unstructured":"Bauer BS, Sandmeyer LS, Philibert H, Feng CX, Grahn BH. Chronic glaucoma in dogs: relationships between histologic lesions and the gonioscopic diagnosis of pectinate ligament dysplasia. Vet Pathol. 2016;53(6):1197\u20131203. doi: 10.1177\/0300985816642276"},{"key":"ref38","series-title":"National Library of Medicine (US), National Center for Biotechnology Information","unstructured":"Basic Local Alignment Search Tool. National Library of Medicine (US), National Center for Biotechnology Information. Accessed November 29, 2018. https:\/\/www.ncbi.nlm.nih.gov\/gene\/"},{"issue":"24","key":"ref39","series-title":"Int J Mol Sci.","first-page":"9739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco GA","year":"2020","unstructured":"Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C,  The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020;21(24):9739. doi: 10.3390\/ijms21249739"},{"key":"ref40","series-title":"Matrix Biol.","first-page":"247","article-title":"The role of TIMPs in regulation of extracellular matrix proteolysis","volume":"44\u201346","author":"Arpino V","year":"2015","unstructured":"Arpino V, Brock M, Gill SE. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 2015;44\u201346:247\u2013254. doi: 10.1016\/j.matbio.2015.03.005"},{"issue":"5","key":"ref41","series-title":"Cells.","first-page":"1313","article-title":"Metalloproteinases and their inhibitors: potential for the development of new therapeutics","volume":"9","author":"Raeeszadeh-Sarmazdeh M","year":"2020","unstructured":"Raeeszadeh-Sarmazdeh M, Do LD, Hritz BG. Metalloproteinases and their inhibitors: potential for the development of new therapeutics. Cells. 2020;9(5):1313. doi: 10.3390\/cells9051313"},{"issue":"9","key":"ref42","series-title":"Expert Opin Pharmacother.","first-page":"885","article-title":"Topical treatment of glaucoma: established and emerging pharmacology","volume":"18","author":"Dikopf MS","year":"2017","unstructured":"Dikopf MS, Vajaranant TS, Edward DP. Topical treatment of glaucoma: established and emerging pharmacology. Expert Opin Pharmacother. 2017;18(9):885\u2013898. doi: 10.1080\/14656566.2017.1328498"},{"key":"ref43","series-title":"Phytomedicine.","first-page":"207","article-title":"The fungus-derived retinoprotectant theissenolactone C improves glaucoma-like injury mediated by MMP-9 inhibition","volume":"56","author":"Lin FL","year":"2019","unstructured":"Lin FL, Cheng YW, Yu M,  The fungus-derived retinoprotectant theissenolactone C improves glaucoma-like injury mediated by MMP-9 inhibition. Phytomedicine. 2019;56:207\u2013214. doi: 10.1016\/j.phymed.2018.11.002"},{"issue":"11","key":"ref44","series-title":"Expert Opin Ther Targets.","first-page":"1037","article-title":"Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway","volume":"21","author":"O\u2019Callaghan J","year":"2017","unstructured":"O\u2019Callaghan J, Cassidy PS, Humphries P. Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway. Expert Opin Ther Targets. 2017;21(11):1037\u20131050."},{"issue":"7","key":"ref45","series-title":"Hum Mol Genet.","first-page":"1230","article-title":"Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma","volume":"26","author":"O\u2019Callaghan J","year":"2017","unstructured":"O\u2019Callaghan J, Crosbie DE, Cassidy PS,  Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma. Hum Mol Genet. 2017;26(7):1230\u20131246. doi: 10.1093\/hmg\/ddx028"},{"issue":"9","key":"ref46","series-title":"Curr Eye Res.","first-page":"952","article-title":"Vitamin E reduces TGF-beta2-induced changes in human trabecular meshwork cells","volume":"38","author":"Yu AL","year":"2013","unstructured":"Yu AL, Moriniere J, Welge-Lussen U. Vitamin E reduces TGF-beta2-induced changes in human trabecular meshwork cells. Curr Eye Res. 2013;38(9):952\u2013958. doi: 10.3109\/02713683.2013.793360"},{"issue":"6","key":"ref47","series-title":"Invest Ophthalmol Vis Sci.","first-page":"2634","article-title":"Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork","volume":"48","author":"Kelley MJ","year":"2007","unstructured":"Kelley MJ, Rose AY, Song K,  Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork. Invest Ophthalmol Vis Sci. 2007;48(6):2634\u20132643. doi: 10.1167\/iovs.06-1445"},{"key":"ref48","series-title":"J Glaucoma.","first-page":"S15","article-title":"The trabecular meshwork in normal eyes and in exfoliation glaucoma","volume":"23","author":"Rasmussen CA","year":"2014","unstructured":"Rasmussen CA, Kaufman PL. The trabecular meshwork in normal eyes and in exfoliation glaucoma. J Glaucoma. 2014;23:S15\u2013S19. doi: 10.1097\/IJG.0000000000000106"},{"issue":"3","key":"ref49","series-title":"Invest Ophthalmol Vis Sci.","first-page":"1953","article-title":"MMPs in the neuroretina and optic nerve: modulators of glaucoma pathogenesis and repair?","volume":"55","author":"De Groef L","year":"2014","unstructured":"De Groef L, Van Hove I, Dekeyster E, Stalmans I, Moons L. MMPs in the neuroretina and optic nerve: modulators of glaucoma pathogenesis and repair? Invest Ophthalmol Vis Sci. 2014;55(3):1953\u20131964. doi: 10.1167\/iovs.13-13630"},{"issue":"2","key":"ref50","series-title":"Curr Opin Ophthalmol.","first-page":"90","article-title":"Collagen degradation in glaucoma: will it gain a therapeutic value?","volume":"11","author":"La Rosa FA","year":"2000","unstructured":"La Rosa FA, Lee DA. Collagen degradation in glaucoma: will it gain a therapeutic value? Curr Opin Ophthalmol. 2000;11(2):90\u201393. doi: 10.1097\/00055735-200004000-00004"},{"issue":"4","key":"ref51","series-title":"J Ocul Pharmacol Ther.","first-page":"208","article-title":"Matrix metalloproteinases and glaucoma treatment","volume":"36","author":"Weinreb RN","year":"2020","unstructured":"Weinreb RN, Robinson MR, Dibas M, Stamer WD. Matrix metalloproteinases and glaucoma treatment. J Ocul Pharmacol Ther. 2020;36(4):208\u2013228. doi: 10.1089\/jop.2019.0146"},{"issue":"10","key":"ref52","series-title":"Arch Ophthalmol.","first-page":"1319","article-title":"Collagen metabolism in human aqueous humor from primary open-angle glaucoma. Decreased degradation and increased biosynthesis play a role in its pathogenesis","volume":"113","author":"Gonz\u00e1lez-Avila G","year":"1995","unstructured":"Gonz\u00e1lez-Avila G, Ginebra M, Hayakawa T, Vadillo-Ortega F, Ter\u00e1n L, Selman M. Collagen metabolism in human aqueous humor from primary open-angle glaucoma. Decreased degradation and increased biosynthesis play a role in its pathogenesis. Arch Ophthalmol. 1995;113(10):1319\u20131323. doi: 10.1001\/archopht.1995.01100100107039"},{"issue":"1","key":"ref53","series-title":"Ophthalmic Res.","first-page":"62","article-title":"Higher TGF-\u03b21, TGF-\u03b22, MMP-2 and TIMP-1 levels in the aqueous humor of patients with acute primary angle closure","volume":"64","author":"Chen Y","year":"2021","unstructured":"Chen Y, Yan H, Li G, Zhang Y. Higher TGF-\u03b21, TGF-\u03b22, MMP-2 and TIMP-1 levels in the aqueous humor of patients with acute primary angle closure. Ophthalmic Res. 2021;64(1):62\u201367. doi: 10.1159\/000507762"},{"key":"ref54","series-title":"Am J Ophthalmol.","first-page":"144","article-title":"Imbalance of matrix metalloproteinases and their inhibitors is correlated with trabeculectomy outcomes in acute primary angle closure","volume":"212","author":"Qian T","year":"2020","unstructured":"Qian T, Fu M, Hu C, Zhang Z, Xu X, Zou H. Imbalance of matrix metalloproteinases and their inhibitors is correlated with trabeculectomy outcomes in acute primary angle closure. Am J Ophthalmol. 2020;212:144\u2013152. doi: 10.1016\/j.ajo.2019.12.014"},{"issue":"10","key":"ref55","series-title":"PLoS One.","first-page":"e0165314","article-title":"Changes to the aqueous humor proteome during glaucoma","volume":"11","author":"Kaeslin MA","year":"2016","unstructured":"Kaeslin MA, Killer HE, Fuhrer CA, Zeleny N, Huber AR, Neutzner A. Changes to the aqueous humor proteome during glaucoma. PLoS One. 2016;11(10):e0165314. doi: 10.1371\/journal.pone.0165314"},{"key":"ref56","series-title":"Mol Vis.","first-page":"1420","article-title":"Matrix metalloproteinase-9 genetic variation and primary angle closure glaucoma in a Caucasian population","volume":"17","author":"Awadalla MS","year":"2011","unstructured":"Awadalla MS, Burdon KP, Kuot A, Hewitt AW, Craig JE. Matrix metalloproteinase-9 genetic variation and primary angle closure glaucoma in a Caucasian population. Mol Vis. 2011;17:1420\u20131424."},{"issue":"4","key":"ref57","series-title":"Invest Ophthalmol Vis Sci.","first-page":"1105","article-title":"Association of gene polymorphisms with primary open angle glaucoma: a systematic review and meta-analysis","volume":"60","author":"Chen M","year":"2019","unstructured":"Chen M, Yu X, Xu J,  Association of gene polymorphisms with primary open angle glaucoma: a systematic review and meta-analysis. Invest Ophthalmol Vis Sci. 2019;60(4):1105\u20131121. doi: 10.1167\/iovs.18-25922"},{"issue":"3","key":"ref58","series-title":"Ophthalmic Genet.","first-page":"211","article-title":"Matrix metalloproteinase-1 rs1799750 polymorphism and glaucoma: a meta-analysis","volume":"38","author":"He M","year":"2017","unstructured":"He M, Wang W, Han X, Huang W. Matrix metalloproteinase-1 rs1799750 polymorphism and glaucoma: a meta-analysis. Ophthalmic Genet. 2017;38(3):211\u2013216. doi: 10.1080\/13816810.2016.1193877"},{"issue":"1","key":"ref59","series-title":"Ophthalmic Genet.","first-page":"41","article-title":"The protective role of the -735C\/T and the -1306C\/T polymorphisms of the MMP-2 gene in the development of primary open-angle glaucoma","volume":"35","author":"Kaminska A","year":"2014","unstructured":"Kaminska A, Banas-Lezanska P, Przybylowska K,  The protective role of the -735C\/T and the -1306C\/T polymorphisms of the MMP-2 gene in the development of primary open-angle glaucoma. Ophthalmic Genet. 2014;35(1):41\u201346. doi: 10.3109\/13816810.2013.800892"},{"issue":"7","key":"ref60","series-title":"Acta Ophthalmol.","first-page":"e516","article-title":"Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1\u03b2 and TIMP1 and the risk of primary open-angle glaucoma","volume":"91","author":"Markiewicz L","year":"2013","unstructured":"Markiewicz L, Majsterek I, Przybylowska K,  Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1\u03b2 and TIMP1 and the risk of primary open-angle glaucoma. Acta Ophthalmol. 2013;91(7):e516\u2013e523. doi: 10.1111\/aos.12149"},{"issue":"1","key":"ref61","series-title":"BMC Ophthalmol.","first-page":"48","article-title":"Associations between matrix metalloproteinase gene polymorphisms and glaucoma susceptibility: a meta-analysis","volume":"17","author":"Wu MY","year":"2017","unstructured":"Wu MY, Wu Y, Zhang Y,  Associations between matrix metalloproteinase gene polymorphisms and glaucoma susceptibility: a meta-analysis. BMC Ophthalmol. 2017;17(1):48. doi: 10.1186\/s12886-017-0442-2"},{"issue":"4","key":"ref62","series-title":"Ophthalmic Res.","first-page":"172","article-title":"Association of MMP-9 gene polymorphisms with glaucoma: a meta-analysis","volume":"55","author":"Zhang Y","year":"2016","unstructured":"Zhang Y, Wang M, Zhang S. Association of MMP-9 gene polymorphisms with glaucoma: a meta-analysis. Ophthalmic Res. 2016;55(4):172\u2013179. doi: 10.1159\/000443627"},{"issue":"13","key":"ref63","series-title":"Eur Rev Med Pharmacol Sci.","first-page":"5542","article-title":"Correlations of TIMP2 and TIMP3 gene polymorphisms with primary open-angle glaucoma","volume":"23","author":"Ji ML","year":"2019","unstructured":"Ji ML, Jia J. Correlations of TIMP2 and TIMP3 gene polymorphisms with primary open-angle glaucoma. Eur Rev Med Pharmacol Sci. 2019;23(13):5542\u20135547. doi: 10.26355\/eurrev_201907_18287"},{"issue":"3","key":"ref64","series-title":"Int J Ophthalmol.","first-page":"397","article-title":"The association between matrix metalloprotease-9 gene polymorphisms and primary angle-closure glaucoma in a Chinese Han population","volume":"7","author":"Gao XJ","year":"2014","unstructured":"Gao XJ, Hou SP, Li PH. The association between matrix metalloprotease-9 gene polymorphisms and primary angle-closure glaucoma in a Chinese Han population. Int J Ophthalmol. 2014;7(3):397\u2013402. doi: 10.3980\/j.issn.2222-3959.2014.03.02"},{"key":"ref65","series-title":"Mol Vis.","first-page":"1223","article-title":"The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients","volume":"12","author":"Wang IJ","year":"2006","unstructured":"Wang IJ, Chiang TH, Shih YF,  The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients. Mol Vis. 2006;12:1223\u20131232."},{"issue":"1","key":"ref66","series-title":"Am J Vet Res.","first-page":"98","article-title":"Evaluation of ADAMTS17 in Chinese Shar-Pei with primary open-angle glaucoma, primary lens luxation, or both","volume":"79","author":"Oliver JAC","year":"2018","unstructured":"Oliver JAC, Rustidge S, Pettitt L,  Evaluation of ADAMTS17 in Chinese Shar-Pei with primary open-angle glaucoma, primary lens luxation, or both. Am J Vet Res. 2018;79(1):98\u2013106. doi: 10.2460\/ajvr.79.1.98"},{"issue":"2","key":"ref67","series-title":"PLoS Genet.","first-page":"e1001306","article-title":"Mapping of the disease locus and identification of ADAMTS10 as a candidate gene in a canine model of primary open angle glaucoma","volume":"7","author":"Kuchtey J","year":"2011","unstructured":"Kuchtey J, Olson LM, Rinkoski T,  Mapping of the disease locus and identification of ADAMTS10 as a candidate gene in a canine model of primary open angle glaucoma. PLoS Genet. 2011;7(2):e1001306. doi: 10.1371\/journal.pgen.1001306"},{"issue":"12","key":"ref68","series-title":"PLoS One.","first-page":"e0143546","article-title":"A novel genome-wide association study approach using genotyping by exome sequencing leads to the identification of a primary open angle glaucoma associated inversion disrupting ADAMTS17","volume":"10","author":"Forman OP","year":"2015","unstructured":"Forman OP, Pettitt L, Kom\u00e1romy AM, Bedford P, Mellersh C. A novel genome-wide association study approach using genotyping by exome sequencing leads to the identification of a primary open angle glaucoma associated inversion disrupting ADAMTS17. PLoS One. 2015;10(12):e0143546. doi: 10.1371\/journal.pone.0143546"},{"issue":"12","key":"ref69","series-title":"Invest Ophthalmol Vis Sci.","first-page":"5308","article-title":"Myocilin regulates metalloprotease 2 activity through interaction with TIMP3","volume":"58","author":"Joe MK","year":"2017","unstructured":"Joe MK, Lieberman RL, Nakaya N, Tomarev SI. Myocilin regulates metalloprotease 2 activity through interaction with TIMP3. Invest Ophthalmol Vis Sci. 2017;58(12):5308\u20135318. doi: 10.1167\/iovs.16-20336"},{"issue":"6","key":"ref70","series-title":"Exp Eye Res.","first-page":"1002","article-title":"First look at the effect of overexpression of TIGR\/MYOC on the transcriptome of the human trabecular meshwork","volume":"82","author":"Borr\u00e1s T","year":"2006","unstructured":"Borr\u00e1s T, Bryant PA, Chisolm SS. First look at the effect of overexpression of TIGR\/MYOC on the transcriptome of the human trabecular meshwork. Exp Eye Res. 2006;82(6):1002\u20131010. doi: 10.1016\/j.exer.2005.11.005"},{"key":"ref71","series-title":"Exp Eye Res.","first-page":"38","article-title":"Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells","volume":"155","author":"Li G","year":"2017","unstructured":"Li G, Cui G, Dismuke WM,  Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells. Exp Eye Res. 2017;155:38\u201346. doi: 10.1016\/j.exer.2016.12.002"},{"issue":"14","key":"ref72","series-title":"Invest Ophthalmol Vis Sci.","first-page":"6058","article-title":"Expression of mutant myocilin induces abnormal intracellular accumulation of selected extracellular matrix proteins in the trabecular meshwork","volume":"57","author":"Kasetti RB","year":"2016","unstructured":"Kasetti RB, Phan TN, Millar JC, Zode GS. Expression of mutant myocilin induces abnormal intracellular accumulation of selected extracellular matrix proteins in the trabecular meshwork. Invest Ophthalmol Vis Sci. 2016;57(14):6058\u20136069. doi: 10.1167\/iovs.16-19610"},{"issue":"12","key":"ref73","series-title":"Invest Ophthalmol Vis Sci.","first-page":"5319","article-title":"Another piece of the puzzle: MYOC and myocilin glaucoma","volume":"58","author":"Fini ME","year":"2017","unstructured":"Fini ME. Another piece of the puzzle: MYOC and myocilin glaucoma. Invest Ophthalmol Vis Sci. 2017;58(12):5319. doi: 10.1167\/iovs.17-23045"},{"issue":"4","key":"ref74","series-title":"Vet Ophthalmol.","first-page":"234","article-title":"Myocilin protein levels in the aqueous humor of the glaucomas in selected canine breeds","volume":"11","author":"MacKay EO","year":"2008","unstructured":"MacKay EO, Kallberg ME, Barrie KP,  Myocilin protein levels in the aqueous humor of the glaucomas in selected canine breeds. Vet Ophthalmol. 2008;11(4):234\u2013241. doi: 10.1111\/j.1463-5224.2008.00631.x"},{"issue":"3","key":"ref75","series-title":"Vet Ophthalmol.","first-page":"177","article-title":"Aqueous humor myocilin protein levels in normal, genetic carriers, and glaucoma Beagles","volume":"11","author":"Mackay EO","year":"2008","unstructured":"Mackay EO, K\u00e4llberg ME, Gelatt KN. Aqueous humor myocilin protein levels in normal, genetic carriers, and glaucoma Beagles. Vet Ophthalmol. 2008;11(3):177\u2013185. doi: 10.1111\/j.1463-5224.2008.00617.x"},{"issue":"suppl 1","key":"ref76","series-title":"Vet Ophthalmol.","first-page":"28","article-title":"Immunolocalization of myocilin protein in the anterior eye of normal and primary open-angle glaucomatous dogs","volume":"10","author":"Hart H","year":"2007","unstructured":"Hart H, Samuelson DA, Tajwar H,  Immunolocalization of myocilin protein in the anterior eye of normal and primary open-angle glaucomatous dogs. Vet Ophthalmol. 2007;10(suppl 1):28\u201337. doi: 10.1111\/j.1463-5224.2007.00517.x"},{"issue":"10","key":"ref77","series-title":"Graefes Arch Clin Exp Ophthalmol.","first-page":"1435","article-title":"Autosomal recessive primary open angle glaucoma (POAG) in Beagles is not associated with mutations in the myocilin (MYOC) gene","volume":"247","author":"Kato K","year":"2009","unstructured":"Kato K, Sasaki N, Gelatt KN, Mackay EO, Shastry BS. Autosomal recessive primary open angle glaucoma (POAG) in Beagles is not associated with mutations in the myocilin (MYOC) gene. Graefes Arch Clin Exp Ophthalmol. 2009;247(10):1435\u20131436. doi: 10.1007\/s00417-009-1053-2"},{"issue":"suppl 1","key":"ref78","series-title":"Vet Ophthalmol.","first-page":"53","article-title":"Cloning of canine myocilin cDNA and molecular analysis of the myocilin gene in Shiba Inu dogs","volume":"10","author":"Kato K","year":"2007","unstructured":"Kato K, Sasaki N, Matsunaga S, Nishimura R, Ogawa H. Cloning of canine myocilin cDNA and molecular analysis of the myocilin gene in Shiba Inu dogs. Vet Ophthalmol. 2007;10(suppl 1):53\u201362. doi: 10.1111\/j.1463-5224.2007.00530.x"},{"issue":"18","key":"ref79","series-title":"Int J Mol Sci.","first-page":"4506","article-title":"The role of MMP8 in cancer: a systematic review","volume":"20","author":"Juurikka K","year":"2019","unstructured":"Juurikka K, Butler GS, Salo T, Nyberg P, Astr\u00f6m P. The role of MMP8 in cancer: a systematic review. Int J Mol Sci. 2019;20(18):4506. doi: 10.3390\/ijms20184506"},{"issue":"3","key":"ref80","series-title":"J Glaucoma.","first-page":"229","article-title":"Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma","volume":"15","author":"M\u00e4\u00e4tt\u00e4 M","year":"2006","unstructured":"M\u00e4\u00e4tt\u00e4 M, Tervahartiala T, Vesti E, Airaksinen J, Sorsa T. Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma. J Glaucoma. 2006;15(3):229\u2013237. doi: 10.1097\/01.ijg.0000212229.57922.72"},{"key":"ref81","series-title":"F1000Res.","article-title":"Recent advances in understanding the regulation of metalloproteinases","volume":"8","author":"Young DA","year":"2019","unstructured":"Young DA, Barter MJ, Wilkinson DJ. Recent advances in understanding the regulation of metalloproteinases. F1000Res. 2019;8:F1000. doi: 10.12688\/f1000research.17471.1"},{"key":"ref82","series-title":"Matrix Biol.","first-page":"255","article-title":"Extracellular regulation of metalloproteinases","volume":"44\u201346","author":"Yamamoto K","year":"2015","unstructured":"Yamamoto K, Murphy G, Troeberg L. Extracellular regulation of metalloproteinases. Matrix Biol. 2015;44\u201346:255\u2013263. doi: 10.1016\/j.matbio.2015.02.007"},{"issue":"3","key":"ref83","series-title":"Ophthalmologica.","first-page":"147","article-title":"Trabecular meshwork phagocytosis in glaucomatous eyes","volume":"211","author":"Matsumoto Y","year":"1997","unstructured":"Matsumoto Y, Johnson DH. Trabecular meshwork phagocytosis in glaucomatous eyes. Ophthalmologica. 1997;211(3):147\u2013152. doi: 10.1159\/000310782"},{"issue":"9","key":"ref84","series-title":"J Cell Physiol.","first-page":"1876","article-title":"The outflow pathway: a tissue with morphological and functional unity","volume":"231","author":"Sacc\u00e0 SC","year":"2016","unstructured":"Sacc\u00e0 SC, Gandolfi S, Bagnis A,  The outflow pathway: a tissue with morphological and functional unity. J Cell Physiol. 2016;231(9):1876\u20131893. doi: 10.1002\/jcp.25305"},{"issue":"16","key":"ref85","series-title":"Int J Mol Sci.","first-page":"3847","article-title":"Matrix metalloproteases as influencers of the cells\u2019 social media","volume":"20","author":"Young D","year":"2019","unstructured":"Young D, Das N, Anowai A, Dufour A. Matrix metalloproteases as influencers of the cells\u2019 social media. Int J Mol Sci. 2019;20(16):3847. doi: 10.3390\/ijms20163847"},{"issue":"2","key":"ref86","series-title":"Vet J.","first-page":"126","article-title":"Canine TIMP-2: purification, characterization and molecular detection","volume":"160","author":"Bee A","year":"2000","unstructured":"Bee A, Barnes A, Jones MD, Robertson DH, Clegg PD, Carter SD. Canine TIMP-2: purification, characterization and molecular detection. Vet J. 2000;160(2):126\u2013134. doi: 10.1053\/tvjl.2000.0467"},{"issue":"3","key":"ref87","series-title":"Vet Pathol.","first-page":"397","article-title":"Canine dilated cardiomyopathy: diffuse remodeling, focal lesions, and the involvement of macrophages and new vessel formation","volume":"57","author":"Gasparini S","year":"2020","unstructured":"Gasparini S, Fonfara S, Kitz S, Hetzel U, Kipar A. Canine dilated cardiomyopathy: diffuse remodeling, focal lesions, and the involvement of macrophages and new vessel formation. Vet Pathol. 2020;57(3):397\u2013408. doi: 10.1177\/0300985820906895"},{"issue":"6","key":"ref88","series-title":"J Vet Intern Med.","first-page":"1816","article-title":"Gene expression of matrix metalloproteinases and their inhibitors (TIMPs) in meningiomas of dogs","volume":"31","author":"Mandara MT","year":"2017","unstructured":"Mandara MT, Reginato A, Foiani G, De Luca S, Guelfi G. Gene expression of matrix metalloproteinases and their inhibitors (TIMPs) in meningiomas of dogs. J Vet Intern Med. 2017;31(6):1816\u20131821. doi: 10.1111\/jvim.14809"},{"issue":"3","key":"ref89","series-title":"Res Vet Sci.","first-page":"560","article-title":"Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-\u03b2 (TGF-\u03b2) in advanced canine myxomatous mitral valve disease","volume":"97","author":"Moesgaard SG","year":"2014","unstructured":"Moesgaard SG, Aupperle H, Rajam\u00e4ki MM,  Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-\u03b2 (TGF-\u03b2) in advanced canine myxomatous mitral valve disease. Res Vet Sci. 2014;97(3):560\u2013567. doi: 10.1016\/j.rvsc.2014.10.003"},{"issue":"2","key":"ref90","series-title":"Am J Vet Res.","first-page":"216","article-title":"Expression of matrix metalloproteinases, their inhibitors, and lysyl oxidase in myocardial samples from dogs with end-stage systemic and cardiac diseases","volume":"74","author":"Fonfara S","year":"2013","unstructured":"Fonfara S, Hetzel U, Tew SR, Cripps P, Dukes-McEwan J, Clegg PD. Expression of matrix metalloproteinases, their inhibitors, and lysyl oxidase in myocardial samples from dogs with end-stage systemic and cardiac diseases. Am J Vet Res. 2013;74(2):216\u2013223. doi: 10.2460\/ajvr.74.2.216"},{"issue":"2","key":"ref91","series-title":"Vet J.","first-page":"260","article-title":"Matrix metalloproteinases and vascular endothelial growth factor expression in canine leukaemias","volume":"196","author":"Aric\u00f2 A","year":"2013","unstructured":"Aric\u00f2 A, Giantin M, Gelain M,  Matrix metalloproteinases and vascular endothelial growth factor expression in canine leukaemias. Vet J. 2013;196(2):260\u2013262. doi: 10.1016\/j.tvjl.2012.10.004"},{"issue":"4","key":"ref92","series-title":"J Comp Pathol.","first-page":"419","article-title":"Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours","volume":"147","author":"Giantin M","year":"2012","unstructured":"Giantin M, Aresu L, Benali S,  Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours. J Comp Pathol. 2012;147(4):419\u2013429. doi: 10.1016\/j.jcpa.2012.01.011"},{"issue":"2","key":"ref93","series-title":"Vet Immunol Immunopathol.","first-page":"101","article-title":"Seizure activity in dogs is associated with enhanced TIMP-2 expression of microglia","volume":"146","author":"Stein VM","year":"2012","unstructured":"Stein VM, Genini S, Puff C, Baumg\u00e4rtner W, Tipold A. Seizure activity in dogs is associated with enhanced TIMP-2 expression of microglia. Vet Immunol Immunopathol. 2012;146(2):101\u2013105. doi: 10.1016\/j.vetimm.2012.02.003"},{"issue":"3","key":"ref94","series-title":"Biochem Biophys Res Commun.","first-page":"1201","article-title":"TIMP-2 promotes cell spreading and adhesion via upregulation of Rap1 signaling","volume":"345","author":"Chang H","year":"2006","unstructured":"Chang H, Lee J, Poo H,  TIMP-2 promotes cell spreading and adhesion via upregulation of Rap1 signaling. Biochem Biophys Res Commun. 2006;345(3):1201\u20131206. doi: 10.1016\/j.bbrc.2006.05.044"},{"issue":"2","key":"ref95","series-title":"Cell.","first-page":"171","article-title":"TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism","volume":"114","author":"Seo DW","year":"2003","unstructured":"Seo DW, Li H, Guedez L,  TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003;114(2):171\u2013180. doi: 10.1016\/s0092-8674(03)00551-8"},{"issue":"2","key":"ref96","series-title":"J Cell Physiol.","first-page":"235","article-title":"Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro","volume":"156","author":"Schnaper HW","year":"1993","unstructured":"Schnaper HW, Grant DS, Stetler-Stevenson WG,  Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol. 1993;156(2):235\u2013246. doi: 10.1002\/jcp.1041560204"},{"issue":"2","key":"ref97","series-title":"J Cell Physiol.","first-page":"351","article-title":"Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation","volume":"157","author":"Murphy AN","year":"1993","unstructured":"Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol. 1993;157(2):351\u2013358. doi: 10.1002\/jcp.1041570219"},{"key":"ref98","series-title":"Exp Eye Res.","first-page":"112","article-title":"The many faces of the trabecular meshwork cell","volume":"158","author":"Stamer WD","year":"2017","unstructured":"Stamer WD, Clark AF. The many faces of the trabecular meshwork cell. Exp Eye Res. 2017;158:112\u2013123. doi: 10.1016\/j.exer.2016.07.009"},{"issue":"13","key":"ref99","series-title":"Invest Ophthalmol Vis Sci.","first-page":"2772","article-title":"Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells","volume":"38","author":"Weinreb RN","year":"1997","unstructured":"Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997;38(13):2772\u20132780."},{"issue":"suppl 2","key":"ref100","series-title":"Surv Ophthalmol.","first-page":"S69","article-title":"Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function","volume":"41","author":"Toris CB","year":"1997","unstructured":"Toris CB, Camras CB, Yablonski ME, Brubaker RF. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol. 1997;41(suppl 2):S69\u2013S75. doi: 10.1016\/s0039-6257(97)80010-0"},{"issue":"12","key":"ref101","series-title":"Invest Ophthalmol Vis Sci.","first-page":"3705","article-title":"Latanoprost\u2019s effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells","volume":"43","author":"Anthony TL","year":"2002","unstructured":"Anthony TL, Lindsey JD, Weinreb RN. Latanoprost\u2019s effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. Invest Ophthalmol Vis Sci. 2002;43(12):3705\u20133711."},{"issue":"13","key":"ref102","series-title":"FASEB J.","first-page":"1929","article-title":"Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism","volume":"19","author":"Hinz B","year":"2005","unstructured":"Hinz B, R\u00f6sch S, Ramer R, Tamm ER, Brune K. Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism. FASEB J. 2005;19(13):1929\u20131931. doi: 10.1096\/fj.04-3626fje"},{"issue":"5","key":"ref103","series-title":"Invest Ophthalmol Vis Sci.","first-page":"1706","article-title":"Acute effects of PGF2alpha on MMP-2 secretion from human ciliary muscle cells: a PKC- and ERK-dependent process","volume":"46","author":"Husain S","year":"2005","unstructured":"Husain S, Jafri F, Crosson CE. Acute effects of PGF2alpha on MMP-2 secretion from human ciliary muscle cells: a PKC- and ERK-dependent process. Invest Ophthalmol Vis Sci. 2005;46(5):1706\u20131713. doi: 10.1167\/iovs.04-0993"},{"issue":"12","key":"ref104","series-title":"Invest Ophthalmol Vis Sci.","first-page":"5182","article-title":"Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo","volume":"44","author":"Mietz H","year":"2003","unstructured":"Mietz H, Esser JM, Welsandt G,  Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo. Invest Ophthalmol Vis Sci. 2003;44(12):5182\u20135188. doi: 10.1167\/iovs.02-0462"},{"issue":"3","key":"ref105","series-title":"Invest Ophthalmol Vis Sci.","first-page":"716","article-title":"Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost","volume":"43","author":"Weinreb RN","year":"2002","unstructured":"Weinreb RN, Lindsey JD. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Invest Ophthalmol Vis Sci. 2002;43(3):716\u2013722."},{"issue":"12","key":"ref106","series-title":"Invest Ophthalmol Vis Sci.","first-page":"4368","article-title":"Prostaglandin FP agonists alter metalloproteinase gene expression in sclera","volume":"45","author":"Weinreb RN","year":"2004","unstructured":"Weinreb RN, Lindsey JD, Marchenko G, Marchenko N, Angert M, Strongin A. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera. Invest Ophthalmol Vis Sci. 2004;45(12):4368\u20134377. doi: 10.1167\/iovs.04-0413"},{"key":"ref107","series-title":"BMC Ophthalmol.","article-title":"Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases","volume":"16","author":"Yamada H","year":"2016","unstructured":"Yamada H, Yoneda M, Gosho M, Kato T, Zako M. Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases. BMC Ophthalmol. 2016;16:26. doi: 10.1186\/s12886-016-0202-8"},{"issue":"11","key":"ref108","series-title":"Invest Ophthalmol Vis Sci.","first-page":"4872","article-title":"Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues","volume":"49","author":"Yu AL","year":"2008","unstructured":"Yu AL, Fuchshofer R, Kampik A, Welge-L\u00fcssen U. Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues. Invest Ophthalmol Vis Sci. 2008;49(11):4872\u20134880. doi: 10.1167\/iovs.07-0984"},{"key":"ref109","series-title":"Exp Eye Res.","article-title":"Effect of prostaglandin analogs: latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells","volume":"194","author":"Heo JY","year":"2020","unstructured":"Heo JY, Ooi YH, Rhee DJ. Effect of prostaglandin analogs: latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells. Exp Eye Res. 2020;194:108019. doi: 10.1016\/j.exer.2020.108019"},{"issue":"1","key":"ref110","series-title":"Can J Ophthalmol.","first-page":"6","article-title":"Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients","volume":"50","author":"Pradhan ZS","year":"2015","unstructured":"Pradhan ZS, Dalvi RA, Lai T, Kranemann C, Boyd S, Birt CM. Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients. Can J Ophthalmol. 2015;50(1):6\u201310. doi: 10.1016\/j.jcjo.2014.10.006"},{"issue":"2","key":"ref111","series-title":"Exp Eye Res.","first-page":"319","article-title":"Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma","volume":"82","author":"Konstas AG","year":"2006","unstructured":"Konstas AG, Koliakos GG, Karabatsas CH,  Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma. Exp Eye Res. 2006;82(2):319\u2013322. doi: 10.1016\/j.exer.2005.07.004"},{"key":"ref112","series-title":"Eur J Pharmacol.","first-page":"57","article-title":"Glucocorticoid therapy and ocular hypertension","volume":"787","author":"Dibas A","year":"2016","unstructured":"Dibas A, Yorio T. Glucocorticoid therapy and ocular hypertension. Eur J Pharmacol. 2016;787:57\u201371. doi: 10.1016\/j.ejphar.2016.06.018"},{"issue":"1","key":"ref113","series-title":"J Ocul Pharmacol Ther.","first-page":"57","article-title":"The ocular hypertensive effects of topical 0.1% dexamethasone in Beagles with inherited glaucoma","volume":"14","author":"Gelatt KN","year":"1998","unstructured":"Gelatt KN, Mackay EO. The ocular hypertensive effects of topical 0.1% dexamethasone in Beagles with inherited glaucoma. J Ocul Pharmacol Ther. 1998;14(1):57\u201366. doi: 10.1089\/jop.1998.14.57"},{"issue":"3","key":"ref114","series-title":"Vet Ophthalmol.","first-page":"195","article-title":"Efficacy of prophylactic antiglaucoma and anti-inflammatory medications in canine primary angle-closure glaucoma: a multicenter retrospective study (2004\u20132012)","volume":"17","author":"Dees DD","year":"2014","unstructured":"Dees DD, Fritz KJ, Maclaren NE,  Efficacy of prophylactic antiglaucoma and anti-inflammatory medications in canine primary angle-closure glaucoma: a multicenter retrospective study (2004\u20132012). Vet Ophthalmol. 2014;17(3):195\u2013200. doi: 10.1111\/vop.12069"},{"issue":"6","key":"ref115","series-title":"J Basic Clin Physiol Pharmacol.","article-title":"Effect of dexamethasone on the expression of MMPs, adenosine A1 receptors and NFKB by human trabecular meshwork cells","volume":"31","author":"Mohd Nasir NA","year":"2020","unstructured":"Mohd Nasir NA, Agarwal R, Krasilnikova A, Sheikh Abdul Kadir SH, Iezhitsa I. Effect of dexamethasone on the expression of MMPs, adenosine A1 receptors and NFKB by human trabecular meshwork cells. J Basic Clin Physiol Pharmacol. 2020;31(6). doi: 10.1515\/jbcpp-2019-0373"},{"issue":"4","key":"ref116","series-title":"Exp Eye Res.","first-page":"461","article-title":"Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants","volume":"57","author":"Snyder RW","year":"1993","unstructured":"Snyder RW, Stamer WD, Kramer TR, Seftor RE. Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants. Exp Eye Res. 1993;57(4):461\u2013468. doi: 10.1006\/exer.1993.1148"},{"issue":"5","key":"ref117","series-title":"Invest Ophthalmol Vis Sci.","first-page":"1571","article-title":"Investigations on the role of the fibrinolytic pathway on outflow facility regulation","volume":"60","author":"Hu Y","year":"2019","unstructured":"Hu Y, Barron AO, Gindina S,  Investigations on the role of the fibrinolytic pathway on outflow facility regulation. Invest Ophthalmol Vis Sci. 2019;60(5):1571\u20131580. doi: 10.1167\/iovs.18-25698"},{"issue":"1","key":"ref118","series-title":"Acta Ophthalmol Scand.","first-page":"104","article-title":"Effects of interleukin-1beta and dexamethasone on the expression of matrix metalloprotease mRNA by trabecular cells exposed to elevated hydrostatic pressure","volume":"83","author":"Ehrich D","year":"2005","unstructured":"Ehrich D, Tripathi B, Tripathi R, Duncker G. Effects of interleukin-1beta and dexamethasone on the expression of matrix metalloprotease mRNA by trabecular cells exposed to elevated hydrostatic pressure. Acta Ophthalmol Scand. 2005;83(1):104\u2013108. doi: 10.1111\/j.1600-0420.2005.00372.x"},{"issue":"12","key":"ref119","series-title":"Invest Ophthalmol Vis Sci.","first-page":"3386","article-title":"Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone","volume":"34","author":"Samples JR","year":"1993","unstructured":"Samples JR, Alexander JP, Acott TS. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci. 1993;34(12):3386\u20133395."},{"issue":"pt 3A","key":"ref120","series-title":"Eye (Lond).","first-page":"375","article-title":"Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone","volume":"14","author":"el-Shabrawi Y","year":"2000","unstructured":"el-Shabrawi Y, Eckhardt M, Berghold A,  Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone. Eye (Lond). 2000;14(pt 3A):375\u2013383. doi: 10.1038\/eye.2000.92"},{"issue":"1","key":"ref121","series-title":"Adv Med Sci.","first-page":"6","article-title":"Metalloproteinase 9 and TIMP-1 expression in retina and optic nerve in absolute angle closure glaucoma","volume":"61","author":"Zalewska R","year":"2016","unstructured":"Zalewska R, Resze\u0107 J, Kisielewski W, Mariak Z. Metalloproteinase 9 and TIMP-1 expression in retina and optic nerve in absolute angle closure glaucoma. Adv Med Sci. 2016;61(1):6\u201310. doi: 10.1016\/j.advms.2015.07.007"},{"issue":"8","key":"ref122","series-title":"Invest Ophthalmol Vis Sci.","first-page":"3737","article-title":"Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes","volume":"48","author":"He S","year":"2007","unstructured":"He S, Prasanna G, Yorio T. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. Invest Ophthalmol Vis Sci. 2007;48(8):3737\u20133745. doi: 10.1167\/iovs.06-1138"},{"issue":"4","key":"ref123","series-title":"J Glaucoma.","first-page":"327","article-title":"Effect of cyclical mechanical stretch and exogenous transforming growth factor-beta1 on matrix metalloproteinase-2 activity in lamina cribrosa cells from the human optic nerve head","volume":"13","author":"Kirwan RP","year":"2004","unstructured":"Kirwan RP, Crean JK, Fenerty CH, Clark AF, O\u2019Brien CJ. Effect of cyclical mechanical stretch and exogenous transforming growth factor-beta1 on matrix metalloproteinase-2 activity in lamina cribrosa cells from the human optic nerve head. J Glaucoma. 2004;13(4):327\u2013334. doi: 10.1097\/00061198-200408000-00011"},{"issue":"5","key":"ref124","series-title":"Arch Ophthalmol.","first-page":"666","article-title":"Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head","volume":"118","author":"Yan X","year":"2000","unstructured":"Yan X, Tezel G, Wax MB, Edward DP. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmol. 2000;118(5):666\u2013673. doi: 10.1001\/archopht.118.5.666"},{"issue":"1","key":"ref125","series-title":"Sci Rep.","first-page":"20936","article-title":"Pluripotent epigenetic regulator OBP-801 maintains filtering blebs in glaucoma filtration surgery model","volume":"10","author":"Yamamoto Y","year":"2020","unstructured":"Yamamoto Y, Mukai A, Ikushima T,  Pluripotent epigenetic regulator OBP-801 maintains filtering blebs in glaucoma filtration surgery model. Sci Rep. 2020;10(1):20936. doi: 10.1038\/s41598-020-77811-7"},{"issue":"2","key":"ref126","series-title":"Invest Ophthalmol Vis Sci.","first-page":"849","article-title":"Role of ID proteins in BMP4 inhibition of profibrotic effects of TGF-beta2 in human TM cells","volume":"58","author":"Mody AA","year":"2017","unstructured":"Mody AA, Wordinger RJ, Clark AF. Role of ID proteins in BMP4 inhibition of profibrotic effects of TGF-beta2 in human TM cells. Invest Ophthalmol Vis Sci. 2017;58(2):849\u2013859. doi: 10.1167\/iovs.16-20472"},{"issue":"3","key":"ref127","series-title":"Invest Ophthalmol Vis Sci.","first-page":"1191","article-title":"Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma","volume":"48","author":"Wordinger RJ","year":"2007","unstructured":"Wordinger RJ, Fleenor DL, Hellberg PE,  Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci. 2007;48(3):1191\u20131200. doi: 10.1167\/iovs.06-0296"},{"key":"ref128","series-title":"Exp Eye Res.","first-page":"23","article-title":"Role of the Rho GTPase\/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: bench to bedside research","volume":"158","author":"Rao PV","year":"2017","unstructured":"Rao PV, Pattabiraman PP, Kopczynski C. Role of the Rho GTPase\/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: bench to bedside research. Exp Eye Res. 2017;158:23\u201332. doi: 10.1016\/j.exer.2016.08.023"},{"issue":"9","key":"ref129","series-title":"Invest Ophthalmol Vis Sci.","first-page":"3016","article-title":"Adenosine A1 receptor modulation of MMP-2 secretion by trabecular meshwork cells","volume":"43","author":"Shearer TW","year":"2002","unstructured":"Shearer TW, Crosson CE. Adenosine A1 receptor modulation of MMP-2 secretion by trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2002;43(9):3016\u20133020."},{"issue":"suppl 1","key":"ref130","series-title":"Vet Ophthalmol.","first-page":"75","article-title":"Safety and efficacy of topically administered netarsudil (Rhopressa\u2122) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG)","volume":"24","author":"Leary KA","year":"2021","unstructured":"Leary KA, Lin KT, Steibel JP, Harman CD, Kom\u00e1romy AM. Safety and efficacy of topically administered netarsudil (Rhopressa\u2122) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG). Vet Ophthalmol. 2021;24(suppl 1):75\u201386. doi: 10.1111\/vop.12734"},{"issue":"suppl 1","key":"ref131","series-title":"Vet Ophthalmol.","first-page":"87","article-title":"Effects of 0.02% netarsudil ophthalmic solution on intraocular pressure of normotensive dogs","volume":"24","author":"Yang VY","year":"2021","unstructured":"Yang VY, Miller PE, Keys DA, La Croix NC. Effects of 0.02% netarsudil ophthalmic solution on intraocular pressure of normotensive dogs. Vet Ophthalmol. 2021;24(suppl 1):87\u201395. doi: 10.1111\/vop.12736"},{"issue":"3-4","key":"ref132","series-title":"Pharmacology.","first-page":"178","article-title":"Rosuvastatin inhibits TIMP-2 and promotes myocardial angiogenesis","volume":"93","author":"Siddiqui AJ","year":"2014","unstructured":"Siddiqui AJ, Gustafsson T, Sylven C, Crisby M. Rosuvastatin inhibits TIMP-2 and promotes myocardial angiogenesis. Pharmacology. 2014;93(3-4):178\u2013184. doi: 10.1159\/000360860"},{"issue":"6","key":"ref133","series-title":"Naunyn Schmiedebergs Arch Pharmacol.","first-page":"547","article-title":"Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells","volume":"383","author":"Izidoro-Toledo TC","year":"2011","unstructured":"Izidoro-Toledo TC, Guimaraes DA, Belo VA, Gerlach RF, Tanus-Santos JE. Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch Pharmacol. 2011;383(6):547\u2013554. doi: 10.1007\/s00210-011-0623-0"},{"key":"ref134","series-title":"Exp Eye Res.","first-page":"55","article-title":"Statins reduce TGF-beta2-modulation of the extracellular matrix in cultured astrocytes of the human optic nerve head","volume":"164","author":"Kim ML","year":"2017","unstructured":"Kim ML, Sung KR, Shin JA, Young Yoon J, Yang J. Statins reduce TGF-beta2-modulation of the extracellular matrix in cultured astrocytes of the human optic nerve head. Exp Eye Res. 2017;164:55\u201363. doi: 10.1016\/j.exer.2017.08.004"},{"issue":"6","key":"ref135","series-title":"Invest Ophthalmol Vis Sci.","first-page":"2729","article-title":"The effect of statins on intraocular pressure and on the incidence and progression of glaucoma: a systematic review and meta-analysis","volume":"57","author":"McCann P","year":"2016","unstructured":"McCann P, Hogg RE, Fallis R, Azuara-Blanco A. The effect of statins on intraocular pressure and on the incidence and progression of glaucoma: a systematic review and meta-analysis. Invest Ophthalmol Vis Sci. 2016;57(6):2729\u20132748. doi: 10.1167\/iovs.15-18595"},{"issue":"3","key":"ref136","series-title":"JAMA Ophthalmol.","first-page":"263","article-title":"Association of daily dosage and type of statin agent with risk of open-angle glaucoma","volume":"135","author":"Talwar N","year":"2017","unstructured":"Talwar N, Musch DC, Stein JD. Association of daily dosage and type of statin agent with risk of open-angle glaucoma. JAMA Ophthalmol. 2017;135(3):263\u2013267. doi: 10.1001\/jamaophthalmol.2016.5406"},{"issue":"8","key":"ref137","series-title":"PLoS One.","first-page":"e0237617","article-title":"Comparison between high and low potency statins in the incidence of open-angle glaucoma: a retrospective cohort study in Japanese working-age population","volume":"15","author":"Ooba N","year":"2020","unstructured":"Ooba N, Iwahashi R, Nogami A,  Comparison between high and low potency statins in the incidence of open-angle glaucoma: a retrospective cohort study in Japanese working-age population. PLoS One. 2020;15(8):e0237617. doi: 10.1371\/journal.pone.0237617"},{"issue":"14","key":"ref138","series-title":"Invest Ophthalmol Vis Sci.","first-page":"4548","article-title":"Association of systemic medication exposure with glaucoma progression and glaucoma suspect conversion in the Groningen Longitudinal Glaucoma Study","volume":"60","author":"Pappelis K","year":"2019","unstructured":"Pappelis K, Loiselle AR, Visser S, Jansonius NM. Association of systemic medication exposure with glaucoma progression and glaucoma suspect conversion in the Groningen Longitudinal Glaucoma Study. Invest Ophthalmol Vis Sci. 2019;60(14):4548\u20134555."},{"issue":"3","key":"ref139","series-title":"Ophthalmic Epidemiol.","first-page":"207","article-title":"The influence of oral statin medications on progression of glaucomatous visual field loss: a propensity score analysis","volume":"25","author":"Whigham B","year":"2018","unstructured":"Whigham B, Oddone EZ, Woolson S,  The influence of oral statin medications on progression of glaucomatous visual field loss: a propensity score analysis. Ophthalmic Epidemiol. 2018;25(3):207\u2013214. doi: 10.1080\/09286586.2017.1399427"},{"issue":"8","key":"ref140","series-title":"Ophthalmology.","first-page":"1501","article-title":"Systemic medication and intraocular pressure in a British population: the EPIC-Norfolk Eye Study","volume":"121","author":"Khawaja AP","year":"2014","unstructured":"Khawaja AP, Chan MP, Broadway DC,  Systemic medication and intraocular pressure in a British population: the EPIC-Norfolk Eye Study. Ophthalmology. 2014;121(8):1501\u20131507. doi: 10.1016\/j.ophtha.2014.02.009"},{"issue":"3","key":"ref141","series-title":"JAMA Ophthalmol.","first-page":"196","article-title":"Association of systemic medication use with intraocular pressure in a multiethnic Asian population: the Singapore Epidemiology of Eye Diseases Study","volume":"135","author":"Ho H","year":"2017","unstructured":"Ho H, Shi Y, Chua J,  Association of systemic medication use with intraocular pressure in a multiethnic Asian population: the Singapore Epidemiology of Eye Diseases Study. JAMA Ophthalmol. 2017;135(3):196\u2013202. doi: 10.1001\/jamaophthalmol.2016.5318"},{"issue":"1","key":"ref142","series-title":"PLoS One.","first-page":"e29724","article-title":"Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study","volume":"7","author":"Marcus MW","year":"2012","unstructured":"Marcus MW, M\u00fcskens RP, Ramdas WD,  Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study. PLoS One. 2012;7(1):e29724. doi: 10.1371\/journal.pone.0029724"},{"issue":"3","key":"ref143","series-title":"Ophthalmology.","first-page":"471","article-title":"Simvastatin and disease stabilization in normal tension glaucoma: a cohort study","volume":"117","author":"Leung DY","year":"2010","unstructured":"Leung DY, Li FC, Kwong YY, Tham CC, Chi SC, Lam DS. Simvastatin and disease stabilization in normal tension glaucoma: a cohort study. Ophthalmology. 2010;117(3):471\u2013476. doi: 10.1016\/j.ophtha.2009.08.016"},{"issue":"1","key":"ref144","series-title":"J Curr Ophthalmol.","first-page":"7","article-title":"Therapeutic targets of renin-angiotensin system in ocular disorders","volume":"29","author":"Choudhary R","year":"2016","unstructured":"Choudhary R, Kapoor MS, Singh A, Bodakhe SH. Therapeutic targets of renin-angiotensin system in ocular disorders. J Curr Ophthalmol. 2016;29(1):7\u201316. doi: 10.1016\/j.joco.2016.09.009"},{"issue":"8","key":"ref145","series-title":"Br J Ophthalmol.","first-page":"960","article-title":"Systemic hypertension and glaucoma: mechanisms in common and co-occurrence","volume":"89","author":"Langman MJ","year":"2005","unstructured":"Langman MJ, Lancashire RJ, Cheng KK, Stewart PM. Systemic hypertension and glaucoma: mechanisms in common and co-occurrence. Br J Ophthalmol. 2005;89(8):960\u2013963. doi: 10.1136\/bjo.2004.053397"},{"issue":"8","key":"ref146","series-title":"Curr Med Res Opin.","first-page":"1879","article-title":"Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study","volume":"25","author":"Iskedjian M","year":"2009","unstructured":"Iskedjian M, Walker JH, Desjardins O,  Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study. Curr Med Res Opin. 2009;25(8):1879\u20131888. doi: 10.1185\/03007990903035083"},{"issue":"7","key":"ref147","series-title":"Indian J Ophthalmol.","first-page":"827","article-title":"Fibrinolytic activity in blood and aqueous humour in glaucoma","volume":"31","author":"Mehra KS","year":"1983","unstructured":"Mehra KS, Dube B, Dube RK. Fibrinolytic activity in blood and aqueous humour in glaucoma. Indian J Ophthalmol. 1983;31(7):827\u2013829."},{"issue":"4","key":"ref148","series-title":"J Glaucoma.","first-page":"253","article-title":"The relationship between plasma MMP-9 and TIMP-2 levels and intraocular pressure elevation in diabetic patients after intravitreal triamcinolone injection","volume":"17","author":"Yildirim N","year":"2008","unstructured":"Yildirim N, Sahin A, Erol N, Kara S, Uslu S, Topbas S. The relationship between plasma MMP-9 and TIMP-2 levels and intraocular pressure elevation in diabetic patients after intravitreal triamcinolone injection. J Glaucoma. 2008;17(4):253\u2013256. doi: 10.1097\/IJG.0b013e31815c3a07"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/83\/3\/ajvr.21.04.0062.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/83\/3\/ajvr.21.04.0062.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/83\/3\/ajvr.21.04.0062.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:36:11Z","timestamp":1749616571000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/83\/3\/ajvr.21.04.0062.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":148,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.21.04.0062","relation":{},"ISSN":["0002-9645"],"issn-type":[{"value":"0002-9645","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}